NAMS
#1698
NewAmsterdam Pharma Company N.V. - Ordinary Shares
25.9 0 USD
-0.03%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-3.32%
Monthly Change
-7.27%
6 month change
-25.34%
Year Change
-28.59%
Previous Close
26.7 9
Open
25.9 0
Low
25.9 0
High
25.9 0
Volume
55
Financials
- Market Capitalization 3.1 B
- Employee 100
- Founded 2019
- CEO N/A
- Website www.newamsterdampharma.com
- Headquarter Netherlands
- FIGI N/A
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-20.4
Price to sales ratio
184.61
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1682 |  TARS Tarsus Pharmaceuticals, Inc. - Common Stock | 71.76 USD | -0.22% | -1.54% | +23.98% | +8.63% | 3.15 B USD | ||
| 1689 |  IMNM Immunome, Inc. - Common Stock | 27.57 USD | -4.50% | -4.07% | +19.87% | +189.91% | 3.13 B USD | ||
| 1703 |  IRON Disc Medicine, Inc. - Common Stock | 80.03 USD | -3.05% | +0.19% | +7.90% | +34.46% | 3.07 B USD | ||
| 1704 |  CLDX Celldex Therapeutics, Inc. - Common Stock | 39.12 USD | -3.31% | -2.59% | +4.99% | +43.61% | 3.07 B USD |
Frequently asked questions about NewAmsterdam Pharma Company N.V. Ordinary Shares
What is the NewAmsterdam Pharma Company N.V. Ordinary Shares stock price today?
The current price of NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) is 25.90. Over the past 24 hours, the stock has changed by -3.32%. Follow the NAMS chart for real-time price dynamics.
What is the stock ticker of NewAmsterdam Pharma Company N.V. Ordinary Shares?
NewAmsterdam Pharma Company N.V. Ordinary Shares trades under the ticker NAMS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is NewAmsterdam Pharma Company N.V. Ordinary Shares stock going up?
NAMS has changed by -6.97% over the last week, -7.27% over the last month, and -28.59% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of NewAmsterdam Pharma Company N.V. Ordinary Shares?
NewAmsterdam Pharma Company N.V. Ordinary Shares currently has a market capitalization of 3.1 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were NewAmsterdam Pharma Company N.V. Ordinary Shares earnings last quarter?
Last quarter, NewAmsterdam Pharma Company N.V. Ordinary Shares reported earnings of -0.52 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was NewAmsterdam Pharma Company N.V. Ordinary Shares revenue for the last quarter?
NewAmsterdam Pharma Company N.V. Ordinary Shares reported quarterly revenue of 3.7 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was NewAmsterdam Pharma Company N.V. Ordinary Shares net income for the last quarter?
NewAmsterdam Pharma Company N.V. Ordinary Shares reported net income of -64.14 M for the last quarter. The previous quarter showed -48.44 M, which means net income changed by -32.40%.
How many employees does NewAmsterdam Pharma Company N.V. Ordinary Shares have?
As of the latest available data, NewAmsterdam Pharma Company N.V. Ordinary Shares has 100 employees. Workforce size can provide additional context about the company's scale and operations.
What is NewAmsterdam Pharma Company N.V. Ordinary Shares EBITDA?
NewAmsterdam Pharma Company N.V. Ordinary Shares EBITDA is -67.59 M, and its EBITDA margin is -1 826.16%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy NewAmsterdam Pharma Company N.V. Ordinary Shares stock?
You can buy NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in NewAmsterdam Pharma Company N.V. Ordinary Shares stock?
Investing in NewAmsterdam Pharma Company N.V. Ordinary Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the NAMS chart and related analysis on metatrader.com as part of your research.